Leishmaniasis Research Paper

934 Words4 Pages
Leishmaniasis is a disease discovered in 1756 by Alexander Russell. The disease was officially named in 1901 after a doctor named William Leishman, who developed one of the earliest cases of this skin infection. Leishmaniasis is caused by a parasite that is spread to humans through infected sand flies. The most common type of this disease is cutaneous leishmaniasis. Visceral and mucosal are other types of leishmaniasis. A person is regularly treated with a specific medication based on the type of leishmaniasis. Leishmaniasis subsists in many tropical countries of the world. This disease is not generally found in the United States. Most cases of this disease found in the United States were from people who got infected while traveling out the country. Individuals who travel to these tropical areas can reduce the risk of infection by protective clothing, bed nets and insect repellents (Nettlesman 2014). Leishmaniasis originated in the Eastern Hemisphere. The Eastern Hemisphere includes the following; Middle East, Asia, Africa. This disease can be found in the most tropical regions and Southern Europe. Leishmaniasis can also be found in the Western Hemisphere. The Western Hemisphere includes the following; South America, Mexico and Central America. Leishmaniasis is found in over ninety parts of various countries. Leishmaniasis is most common in Bolivia, Peru, Afghanistan, Iran, Bangladesh, India, Colombia, Saudi Arabia, Syria Nepal, Algeria, and Brazil (Nettleman, 2014). In the United States, Leishmaniasis cases are caused by work and travel. Many people who travel or have jobs in the tropical parts of the world are at risk of getting bite by an infected sand fly and may carry the disease back to the United States. Leishmaniasis... ... middle of paper ... ...y on the country and the facilities available. Liposomal amphotericin, B is used to treat visceral leishmaniasis in the United States. Pentavalent antimony (SbV) paromomycin (Humantin) and miltefosine (Miltex) are used in other countries where liposomal amphotericin is not available (Nettlesman, 2014). Cutaneous sores on average can heal on there own. The healing process may take a long time and disfigured scaring can take place. The treatment offered for cutaneous leishmaniasis is, oral ketoconazol, liposomal amphotericin and intravenous pentamidine (Nettleman, 2014). Unfortunately, there are no set treatments for mucosal leishmaniasis. This type usually has a late development, which may take many years to notice any affects to the body. The most precise thing to do is to ensure appropriate treatment prior to the development of the disease and practice prevention.
Open Document